Clinical Social Workers in Lithia, FL Accepting Medicare

8 Clinical Social Workers found. Showing 1 - 8

Julia Papesch Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16132 Churchview Dr Ste 201, Lithia, FL 33547 Phone: 813-690-0113

Ms. Linda Maria Dorremocea, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15829 Fishhawk Falls Dr, Lithia, FL 33547 Phone: 727-831-0131    Fax: 813-654-7684

Shad Fitzpatrick Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1869 Streetman Dr, Lithia, FL 33547 Phone: 813-843-3694

Megan Malinka Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16401 Dunlindale Dr, Lithia, FL 33547 Phone: 727-259-5158

Mrs. Emily Macy Oneill, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5805 Tanagerside Rd, Lithia, FL 33547 Phone: 813-436-9688

Nicole Hunt, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16132 Churchview Dr Ste 201, Lithia, FL 33547 Phone: 585-690-8799

Susan Frederick, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5702 Watercolor Dr, Lithia, FL 33547 Phone: 813-610-2984

Deirdre Parker Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5611 Hawkgrove Pl, Lithia, FL 33547 Phone: 813-546-0974

News Archive

Study: Spiritualists are more likely to report unusual auditory phenomena early in life

Spiritualist mediums might be more prone to immersive mental activities and unusual auditory experiences early in life, according to new research.

H70 study provides data on cognitive symptoms that predict dementia

Today´s 70-year-olds do far better in intelligence tests than their predecessors. It has also become more difficult to detect dementia in its early stages, though forgetfulness is still an early symptom, reveals new research from the University of Gothenburg, Sweden, based on the H70 study.

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.

Read more Medical News

› Verified 4 days ago